Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was marked by a drastic, high-volume liquidation event that quickly erased months of gains....
Forbes - 2/5/2026 3:25:43 PM
More News for BSX
Stock Analysis for BSX
Related Stocks:
New York, New York--(Newsfile Corp. - February 5, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws. On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results....
Newsfile Corp - 2/5/2026 2:34:00 PM
More News for BSX
Stock Analysis for BSX
Related Stocks:
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
Zacks Investment Research - 2/5/2026 11:45:56 AM
More News for BSX
Stock Analysis for BSX
Related Stocks: